Five-Minute SC Injection of Daratumumab in R/R Multiple Myeloma Five-Minute SC Injection of Daratumumab in R/R Multiple Myeloma

The subcutaneous formulation of daratumumab in combination with pomalidomide and dexamethasone showed significant improvement in progression-free survival.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news